Early Hematopoietic Cell Transplantation Improves Survival in Youth with SDS
Audio narration · Coming soon
This report highlights that early hematopoietic cell transplantation (HCT) significantly boosts survival rates in children with Shwachman-Diamond Syndrome (SDS), a rare bone marrow condition. While over 90% of children with SDS survive beyond age 20, fewer than 30% benefit from this treatment, indicating potential for improved outcomes with earlier intervention.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews